| 000 | 01513 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250517100826.0 | ||
| 264 | 0 | _c20170711 | |
| 008 | 201707s 0 0 eng d | ||
| 022 | _a1873-7064 | ||
| 024 | 7 |
_a10.1016/j.neuropharm.2016.06.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVoyer, David | |
| 245 | 0 | 0 |
_aRepeated ventral midbrain neurotensin injections sensitize to amphetamine-induced locomotion and ERK activation: A role for NMDA receptors. _h[electronic resource] |
| 260 |
_bNeuropharmacology _c01 2017 |
||
| 300 |
_a150-163 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAmphetamine _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMesencephalon _xdrug effects |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinase 1 _xmetabolism |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinase 3 _xmetabolism |
| 650 | 0 | 4 |
_aMotor Activity _xdrug effects |
| 650 | 0 | 4 |
_aNeurons _xmetabolism |
| 650 | 0 | 4 |
_aNeurotensin _xadministration & dosage |
| 650 | 0 | 4 |
_aNucleus Accumbens _xdrug effects |
| 650 | 0 | 4 |
_aPrefrontal Cortex _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Long-Evans |
| 650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xantagonists & inhibitors |
| 700 | 1 | _aLévesque, Daniel | |
| 700 | 1 | _aRompré, Pierre-Paul | |
| 773 | 0 |
_tNeuropharmacology _gvol. 112 _gno. Pt A _gp. 150-163 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuropharm.2016.06.005 _zAvailable from publisher's website |
| 999 |
_c26095980 _d26095980 |
||